UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer

Journal for immunotherapy of cancer, 2019-02, Vol.7 (1), p.38-14, Article 38

2019

Volltextzugriff (PDF)

Assessing Similarity Among Individual Tumor Size Lesion Dynamics: The CICIL Methodology

CPT: pharmacometrics and systems pharmacology, 2018-04, Vol.7 (4), p.228-236

2018

Volltextzugriff (PDF)

Flow Cytometric Measurement of Platelet-Leukocyte Aggregates: A Possible Target to Monitor Platelet Function?

Seminars in thrombosis and hemostasis, 2005-08, Vol.31 (4), p.400-403

2005

Volltextzugriff (PDF)

Close relationship between the platelet activation marker CD62 and the granular release of platelet-derived growth factor

The Journal of pharmacology and experimental therapeutics, 2002-03, Vol.300 (3), p.952

2002

Volltextzugriff (PDF)

Flow Cytometric Measurement of Platelet-Leukocyte Aggregates: A Possible Target to Monitor Platelet Function?

Seminars in thrombosis and hemostasis, 2005-08, Vol.31 (4), p.400-403

2005

Volltextzugriff (PDF)

Avoidance of bleeding during surgery in patients receiving anticoagulant and/or antiplatelet therapy: Pharmacokinetic and pharmacodynamic considerations

Clinical pharmacokinetics, 2004, Vol.43 (14), p.963-981

2004

Volltextzugriff (PDF)

Anticoagulation With Argatroban for Elective Percutaneous Coronary Intervention: Population Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Relationship of Coagulation Parameters

Journal of clinical pharmacology, 2011-06, Vol.51 (6), p.805-818

2011

Volltextzugriff (PDF)

A novel μ-fluidic whole blood coagulation assay based on Rayleigh surface-acoustic waves as a point-of-care method to detect anticoagulants

Biomicrofluidics, 2013-09, Vol.7 (5), p.56502-56502

2013

Volltextzugriff (PDF)

408 Phase I, first-in-human trial evaluating BI 1387446 (stimulator of interferon genes [STING] agonist) alone and combined with BI 754091 (anti-programmed cell death [PD]-1) in solid tumors

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A248-A248

2020

Volltextzugriff (PDF)

The integrin antagonist, cilengitide, is a weak inhibitor of αIIbβ3 mediated platelet activation and inhibits platelet adhesion under flow

Platelets (Edinburgh), 2015-02, Vol.26 (1), p.59-66

2015

Volltextzugriff (PDF)

P3.02c-091 Final Phase Ib Results of RNActive® Cancer Vaccine BI 1361849 and Local Radiation as Maintenance Therapy for Stage IV NSCLC

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1333-S1334

2017

Volltextzugriff (PDF)

P3.02c-091 Final Phase Ib Results of RNActive® Cancer Vaccine BI 1361849 and Local Radiation as Maintenance Therapy for Stage IV NSCLC: Topic: IT Clinical

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1333-S1334

2017

Volltextzugriff (PDF)

Using ImageJ for the quantitative analysis of flow-based adhesion assays in real-time under physiologic flow conditions

Platelets (Edinburgh), 2010, Vol.21 (1), p.60-66

2010

Volltextzugriff (PDF)

Flow cytometric measurement of platelet- leukocyte aggregates : A possible target to monitor platelet function?: Reliability of platelet function tests and drug monitoring

Seminars in thrombosis and hemostasis, 2005, Vol.31 (4), p.400-403

2005

Volltextzugriff (PDF)

Platelet–leucocyte adhesion markers before and after the initiation of antiretroviral therapy with HIV protease inhibitors

Journal of antimicrobial chemotherapy, 2008-11, Vol.62 (5), p.1118-1121

2008

Volltextzugriff (PDF)

Avoidance of bleeding during surgery in patients receiving anticoagulant and/or anti-platelet therapy: pharmacokinetic and pharmacodynamic considerations

Clinical pharmacokinetics, 2004-12, Vol.43 (14), p.963

2004

Volltextzugriff (PDF)

Effects of the NHE-1 inhibitor cariporide alone or together with the P2Y12 antagonist AR-C 69331 MX on CD62p expression and formation of platelet-leukocyte aggregates

Thrombosis research, 2003, Vol.111 (4-5), p.251-257

2003

Volltextzugriff (PDF)

A novel ?-fluidic whole blood coagulation assay based on Rayleigh surface-acoustic waves as a point-of-care method to detect anticoagulants

Biomicrofluidics, 2013-01, Vol.7 (5)

2013

Volltextzugriff (PDF)

Pharmacodynamic profile of antiplatelet agents: marked differences between single versus costimulation with platelet activators

Thrombosis research, 2004, Vol.113 (5), p.295-302

2004

Volltextzugriff (PDF)

Effects of the NHE-1 inhibitor cariporide alone or together with the P2Y 12 antagonist AR-C 69331 MX on CD62p expression and formation of platelet–leukocyte aggregates

Thrombosis research, 2003, Vol.111 (4), p.251-257

2003

Volltextzugriff (PDF)

Thrombolytics : Drug interactions of clinical significance

Drug safety, 2000-11, Vol.23 (5), p.391-399

2000

Volltextzugriff (PDF)

Dosis-Wirkungs-Beziehung: Relevanz für die ärztliche Praxis

Medizinische Klinik (München. 1983), 1998-12, Vol.93 (12), p.744-749

1998

Volltextzugriff (PDF)

Role of the Retention Test Homburg in Evaluating Platelet Hyperactivity and in Monitoring Therapy with Antiplatelet Drugs

Seminars in thrombosis and hemostasis, 2005-08, Vol.31 (4), p.458-463

2005

Volltextzugriff (PDF)

Adhesion, Spreading, and Aggregation of Platelets in Flowing Blood and the Reliability of the Retention Test Homburg

Seminars in thrombosis and hemostasis, 2005-08, Vol.31 (4), p.449-457

2005

Volltextzugriff (PDF)

Role of the retention test homburg in evaluating platelet hyperactivity and in monitoring therapy with antiplatelet drugs: Reliability of platelet function tests and drug monitoring

Seminars in thrombosis and hemostasis, 2005, Vol.31 (4), p.458-463

2005

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

KollektionNUS Single-Journal Subscriptions

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(27)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer

Assessing Similarity Among Individual Tumor Size Lesion Dynamics: The CICIL Methodology

Flow Cytometric Measurement of Platelet-Leukocyte Aggregates: A Possible Target to Monitor Platelet Function?

Close relationship between the platelet activation marker CD62 and the granular release of platelet-derived growth factor

Flow Cytometric Measurement of Platelet-Leukocyte Aggregates: A Possible Target to Monitor Platelet Function?

Avoidance of bleeding during surgery in patients receiving anticoagulant and/or antiplatelet therapy: Pharmacokinetic and pharmacodynamic considerations

Anticoagulation With Argatroban for Elective Percutaneous Coronary Intervention: Population Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Relationship of Coagulation Parameters

A novel μ-fluidic whole blood coagulation assay based on Rayleigh surface-acoustic waves as a point-of-care method to detect anticoagulants

408 Phase I, first-in-human trial evaluating BI 1387446 (stimulator of interferon genes [STING] agonist) alone and combined with BI 754091 (anti-programmed cell death [PD]-1) in solid tumors

The integrin antagonist, cilengitide, is a weak inhibitor of αIIbβ3 mediated platelet activation and inhibits platelet adhesion under flow

P3.02c-091 Final Phase Ib Results of RNActive® Cancer Vaccine BI 1361849 and Local Radiation as Maintenance Therapy for Stage IV NSCLC

P3.02c-091 Final Phase Ib Results of RNActive® Cancer Vaccine BI 1361849 and Local Radiation as Maintenance Therapy for Stage IV NSCLC: Topic: IT Clinical

Using ImageJ for the quantitative analysis of flow-based adhesion assays in real-time under physiologic flow conditions

Flow cytometric measurement of platelet- leukocyte aggregates : A possible target to monitor platelet function?: Reliability of platelet function tests and drug monitoring

Platelet–leucocyte adhesion markers before and after the initiation of antiretroviral therapy with HIV protease inhibitors

Avoidance of bleeding during surgery in patients receiving anticoagulant and/or anti-platelet therapy: pharmacokinetic and pharmacodynamic considerations

Effects of the NHE-1 inhibitor cariporide alone or together with the P2Y12 antagonist AR-C 69331 MX on CD62p expression and formation of platelet-leukocyte aggregates

A novel ?-fluidic whole blood coagulation assay based on Rayleigh surface-acoustic waves as a point-of-care method to detect anticoagulants

Pharmacodynamic profile of antiplatelet agents: marked differences between single versus costimulation with platelet activators

Effects of the NHE-1 inhibitor cariporide alone or together with the P2Y 12 antagonist AR-C 69331 MX on CD62p expression and formation of platelet–leukocyte aggregates

Thrombolytics : Drug interactions of clinical significance

Dosis-Wirkungs-Beziehung: Relevanz für die ärztliche Praxis

Role of the Retention Test Homburg in Evaluating Platelet Hyperactivity and in Monitoring Therapy with Antiplatelet Drugs

Adhesion, Spreading, and Aggregation of Platelets in Flowing Blood and the Reliability of the Retention Test Homburg

Role of the retention test homburg in evaluating platelet hyperactivity and in monitoring therapy with antiplatelet drugs: Reliability of platelet function tests and drug monitoring

Aktive Filter

Suchergebnisse filtern